# Glargine Versus NPH in Patients With Chronic Kidney Disease

> **NCT02451917** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 34 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Chronic Kidney Disease

## Interventions

- **DRUG:** Glargine insulin
- **DRUG:** NPH insulin

## Key facts

- **NCT ID:** NCT02451917
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02451917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02451917, "Glargine Versus NPH in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02451917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*